Stanford-led studies show that physicians supported by AI chatbots match or exceed chatbot-alone performance in nuanced clinical decision-making.
Key Details
- 1Stanford Medicine and partners studied chatbots (LLMs) for clinical management reasoning, including imaging-based decisions.
- 2Chatbots alone outperformed doctors using only online references in nuanced management cases, but doctors with chatbot support performed equally well as chatbots alone.
- 3One randomized trial with 70 doctors found best results when AI and physicians independently reviewed cases, followed by AI-generated summary reconciliation.
- 4Studies involved scenarios such as selecting next steps for lung masses detected in imaging.
- 5Multi-institutional team included Stanford, Harvard, VA Palo Alto, Beth Israel, and others.
- 6Research published in Nature Medicine (February 2025) and Nature Digital Medicine (March 2026).
Why It Matters

Source
EurekAlert
Related News

AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.

AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.

AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.